To test whether androgen modulates ZFHX3 expression, we determined ZFHX3 expression in AR‐positive prostate cancer cell line LNCaP and its derivative C4‐2B under the treatment of the R1881 synthetic androgen.25 Here, AR is linked to prostate carcinoma.